Related references
Note: Only part of the references are listed.AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma
Cory D. Fulcher et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial
Lionnel Geoffrois et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Head and neck cancers are associated with poor EQ-5D-related utility in France (EPICORL study)
M. Schwarzinger et al.
RADIOTHERAPY AND ONCOLOGY (2017)
The life experience of nutrition impact symptoms during treatment for head and neck cancer patients: a systematic review and meta-synthesis
Valentina Bressan et al.
SUPPORTIVE CARE IN CANCER (2017)
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial
M. G. Ghi et al.
ANNALS OF ONCOLOGY (2017)
Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials
Wilfried Budach et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
Jerome Fayette et al.
ONCOTARGET (2016)
Induction docetaxel platinum 5-FU (TPF) followed by cetuximab-radiotherapy (cetux-RT) versus concurrent chemo-radiotherapy (CT/RT) in patients with N2b/c-N3 non operated stage III-IV squamous cell cancer of the head and neck (SCCHN): Results of the GORTEC 2007-02 phase III randomized trial.
Lionnel Geoffrois et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
J. Guigay et al.
ANNALS OF ONCOLOGY (2015)
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer
Zoltan Takacsi-Nagy et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2015)
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
R. Hitt et al.
ANNALS OF ONCOLOGY (2014)
Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
Ezra E. W. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group
Pierre Blanchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study
Jean Louis Lefebvre et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
Robert Haddad et al.
LANCET ONCOLOGY (2013)
Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891
J. -L. Lefebvre et al.
ANNALS OF ONCOLOGY (2012)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
Pierre Blanchard et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study
A. Paccagnella et al.
ANNALS OF ONCOLOGY (2010)
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres
M. Pressoir et al.
BRITISH JOURNAL OF CANCER (2010)
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation
M. R. Posner et al.
ANNALS OF ONCOLOGY (2009)
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
J. L. Lefebvre et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation
Yoann Pointreau et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R. Posner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Critical weight loss in head and neck cancer - prevalence and risk factors at diagnosis: an explorative study
Harriet Jager-Wittenaar et al.
SUPPORTIVE CARE IN CANCER (2007)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer
R Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
AA Forastiere et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:: three meta-analyses of updated individual data
JP Pignon et al.
LANCET (2000)